
Sign up to save your podcasts
Or
We are beginning a new series today. John and Adam will discuss a couple of articles we found interesting. Please let us know your thoughts. This week:
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
Tiotropium Initiation and Dementia Risk in Chronic Obstructive Pulmonary Disease
4.9
132132 ratings
We are beginning a new series today. John and Adam will discuss a couple of articles we found interesting. Please let us know your thoughts. This week:
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
Tiotropium Initiation and Dementia Risk in Chronic Obstructive Pulmonary Disease
32,103 Listeners
500 Listeners
883 Listeners
289 Listeners
259 Listeners
3,339 Listeners
1,149 Listeners
610 Listeners
8,189 Listeners
190 Listeners
756 Listeners
432 Listeners
372 Listeners
1,722 Listeners
390 Listeners